Shanghai, China

Fujiang Guo


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Metabolic Health by Fujiang Guo

Introduction

Fujiang Guo, an esteemed inventor based in Shanghai, China, has made significant contributions to the field of metabolic health through his innovative work. As a researcher at the Shanghai University of Traditional Chinese Medicine, he focuses on developing solutions to combat metabolic syndrome, a growing health concern worldwide. With one patent to his name, Guo's work has the potential to influence both medicine and functional foods.

Latest Patents

Guo holds a patent titled "PPAR α/γ Dual Agonist and Its Application." This transformative invention presents a compound capable of acting as a dual agonist for PPAR α and PPAR γ, which are important targets for treating metabolic disorders. The patent details the use of these compounds in formulating drugs and functional foods aimed at preventing and treating issues related to metabolic syndrome, particularly glucose and lipid disorders. The extensive prospects for application underscore the significance of this innovation.

Career Highlights

Throughout his career at the Shanghai University of Traditional Chinese Medicine, Guo has displayed a commitment to advancing the knowledge and applications of traditional Chinese medicine in contemporary scientific contexts. His research has not only contributed to academic literature but has also paved the way for practical treatments that benefit patients facing metabolic challenges.

Collaborations

Fujiang Guo collaborates with talented professionals in his field, including Cheng Yi Huang and Li Yi Feng. Together, they work on enhancing the effectiveness of traditional approaches by integrating modern scientific methodologies, thereby enriching the research environment at the Shanghai University of Traditional Chinese Medicine.

Conclusion

Fujiang Guo stands as a noteworthy inventor in the field of metabolic health, with his PPAR α/γ dual agonist patent positioned to make substantial contributions to medical and nutritional therapies. His collaboration with skilled colleagues further enhances the potential for impactful innovations in treating metabolic syndrome, emphasizing the bright future of research at the Shanghai University of Traditional Chinese Medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…